The CDC calls their misuse “one of the most serious public health problems in the United States”
Thailand is trying to communicate the risk through museum exhibitions
DNA from the teeth of medieval plague victims indicates the pathogen likely first arrived in eastern Europe before spreading across the continent.
Existing religious and philosophical exemptions endanger public health
The anti-vaccine movement fails to live up to its own rhetoric
A study of 17 patients with the mysterious illnesses revealed inflammation suggestive of inhaled toxic substances
Scientific American senior editor Jen Schwartz talks with WHO officials Maria Neira and Agnès Soucat about climate and health and with Rachel Kyte, special representative to the U.N...
As lung injuries among e-cigarette users mount amid a youth vaping epidemic, the impact of new restrictions remains unclear
Populations of the mosquito species thought to transmit Eastern equine encephalitis have persisted later than usual this year
The FDA has approved a drug combination that could be a game changer. We should make sure its use is equitable and sustainable
The strains chosen for the Southern Hemisphere vaccine suggest the Northern Hemisphere one may not provide optimal protection
Former EPA administrator Gina McCarthy talks with Scientific American’s Andrea Thompson about the widespread benefits of taking action against climate change.
As of this week, there have been 805 confirmed cases and 12 deaths, across 46 states and the U.S. Virgin Islands
Malignancies are on the rise in the most obese generation in history
The e-cigarette maker’s announcement comes in the wake of a controversy over the marketing of its products to youth
“Ultraprocessed” foods seem to trigger neural signals that make us want more and more calories, unlike other foods in the Western diet
Dr. Ellen Hendriksen dives into the history of the epidemic and asks behavior coach Eric Zimmer for his most vital advice on addiction recovery
The 2019 Lasker-Bloomberg Public Service Award is a gratifying validation of the work we do at Gavi, the Vaccine Alliance
Rapid molecular tests for influenza are as quick as older on-the-spot tests and much more accurate. But that might not be enough to drive widespread adoption.
Can the latest techniques speed up the dangerously slow production of flu vaccines?